Trump reported to have personal interest in drug he is pushing for coronavirus

In a story about US President Donald Trump’s promotion of the unproven drug hydroxychloroquine to treat coronavirus, the New York Times reports that the US leader has a small personal interest in French drugmaker Sanofi, which is a producer of the medicine.

There have been some reports that the anti-malaria drug can help patients fighting an infection. But the claim is far from tested and the drug can in some cases of prolonged use cause cardiac issues. Doctors have warned of caution in treating it as any kind of solution at this point.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.